A study to assess preliminary efficacy and tolerability of brentuximab vedotin for patients with Sezary Syndrome
Latest Information Update: 05 Jan 2021
At a glance
- Drugs Brentuximab vedotin (Primary)
- Indications Sezary syndrome
- Focus Therapeutic Use
- 05 Jan 2021 New trial record
- 30 Dec 2020 Results published in the JAMA Dermatology